DRAK2 regulates myosin light chain phosphorylation in T cells
Benjamin A Wilander1,2, Tarsha L Harris1, Alexandra H Mandarano1
1Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Abstract:
Death-associated protein kinase-related apoptosis-inducing kinase-2 (DRAK2; also known as STK17B) is a serine/threonine kinase expressed in T cells. Drak2-deficient (Drak2-/-) mice respond effectively to tumors and pathogens while displaying resistance to T cell-mediated autoimmune disease. However, the molecular mechanisms by which DRAK2 impacts T cell function remain unclear. Gaining further insight into the function of DRAK2 in T cells will shed light on differentially regulated pathways in autoreactive and pathogen-specific T cells, which is crucial for improving autoimmune therapies. Here, we demonstrate that DRAK2 contributes to activation of myosin light chain (MLC2, encoded by Myl2) in both murine and human T cells. In the absence of Drak2, the amount of polymerized actin was decreased, suggesting that DRAK2 modulates actomyosin dynamics. We further show that myosin-dependent T cell functions, such as migration, T cell receptor microcluster accumulation, and conjugation to antigen presenting cells are decreased in the absence of Drak2. These findings reveal that DRAK2 plays an important role in regulating MLC activation within T cells.
Insights
Death-associated protein kinase-related apoptosis-inducing kinase-2 (DRAK2) regulates T cell activation by modulating myosin light chain (MLC2) and actomyosin dynamics. Its absence impairs T cell functions crucial for immune responses and autoimmune disease resistance.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Death-associated protein kinase-related apoptosis-inducing kinase-2 (DRAK2), also known as STK17B, is a serine/threonine kinase found in T cells.
- DRAK2 deficiency in mice confers resistance to autoimmune diseases and enhances anti-tumor and anti-pathogen responses.
- The precise molecular mechanisms of DRAK2's role in T cell function are not fully understood.
Purpose of the Study:
- To elucidate the molecular mechanisms by which DRAK2 influences T cell function.
- To investigate the role of DRAK2 in regulating T cell activation pathways.
- To provide insights into potential therapeutic targets for autoimmune diseases.
Main Methods:
- Investigated DRAK2's effect on myosin light chain (MLC2) activation in murine and human T cells.
- Assessed the impact of DRAK2 deficiency on polymerized actin levels.
- Analyzed myosin-dependent T cell functions, including migration, T cell receptor microcluster formation, and cell conjugation.
Main Results:
- DRAK2 was found to contribute to the activation of MLC2 in both murine and human T cells.
- Absence of DRAK2 led to reduced polymerized actin, indicating modulation of actomyosin dynamics.
- T cell migration, T cell receptor microcluster accumulation, and conjugation to antigen-presenting cells were impaired in Drak2-deficient T cells.
Conclusions:
- DRAK2 plays a significant role in regulating T cell activation through MLC2 activation.
- DRAK2 modulates actomyosin dynamics, impacting essential T cell functions.
- Understanding DRAK2's function is crucial for developing targeted therapies for T cell-mediated autoimmune diseases.
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
02:54Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
01:22Amplifying Signals via Enzymatic Cascade
01:26Receptor Tyrosine Kinases
01:16TGF - β Signaling Pathway
01:16Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...